Ipsilateral or contralateral boosting of mice with mRNA vaccines confers equivalent immunity and protection against a SARS-CoV-2 Omicron strain
Baoling Ying, Chieh-Yu Liang, Pritesh Desai, Suzanne M. Scheaffer, Sayda M. Elbashir, Darin K. Edwards, Larissa B. Thackray, Michael Diamond
This study shows that boosting mice with mRNA vaccines in the ipsilateral or contralateral arm leads to equivalent immune responses and protection against SARS-CoV-2 Omicron.
Journal of Virology · Aug 28, 2024Peer-reviewedMicrobiology